Use of the Retention Index to Secure Correct Identities in GC/MS

Drug products and medical device extracts are chromatographically analysed via non-targeted analysis to detect, identify, and quantify organic leachables; GC/MS addresses primarily volatile and semi-volatile organic leachables. Identities of compounds detected by GC/MS are often secured by mass spectral matching (MSM), where the mass spectrum is compared to reference spectra from a spectral library. Compounds whose reference spectrum closely matches the analytical spectrum are candidate identities for the compound of interest. Even when rigorously applied, MSM can lead to incorrect candidate identities. Avoiding misidentifications is important as reporting misidentified compounds can severely impact toxicological risk assessment, potentially leading to false conclusions about patient safety. The retention index (RI) is an effective means of evaluating an identity secured by MSM. The agreement between an experimental RI and a reference RI likely corroborates or refutes an MSM identity, although in certain cases the RI comparison may be inconclusive. The use of RI matching to corroborate MSM-based identities was investigated. Experimental and calculated RI values from the NIST23 library were compared to experimental RI values. Both classes of NIST23 RI values correlated well with the experimental RI obtained for 3140 compounds with confirmed identities, leading to the development of a strategy where reference RI-information from NIST23 can be used to support, accept, or reject candidate MSM structures. Using a confusion matrix, it is concluded that within the boundaries set for mass spectral matching (MSM>85; top 5 ranked candidates), an absolute difference in RI between the experimental value and the NIST reference value (|ΔRI|) of equal or lower than 20 showed a high identification precision and corroborates proposed identified. A |ΔRI| value higher than 50 showed a very low precision, which consequently rejects these identifications. |ΔRI| values between 20 and 50 are indiscriminate, meaning that while the identity proposed via MSM is accepted, it is considered to be tentative and uncorroborated.

Authors

Institutions

Publication Details

Journal
PDA Journal of Pharmaceutical Science and Technology
Published
2025-08-28
DOI
https://doi.org/10.5731/pdajpst.2025-000008.1
Primary Topic
Metabolomics and Mass Spectrometry Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of the Retention Index to Secure Correct Identities in GC/MS

Dennis Jenke, Piet Christiaens, Jan Baeten, P. Verlinde et al.
PDA Journal of Pharmaceutical Science and Technology
Metabolomics and Mass Spectrometry Studies
article

Use of the Retention Index to Secure Correct Identities in GC/MS

Dennis Jenke, Piet Christiaens, Jan Baeten, P. Verlinde, Jean-Marie Beusen
article en

Abstract

Drug products and medical device extracts are chromatographically analysed via non-targeted analysis to detect, identify, and quantify organic leachables; GC/MS addresses primarily volatile and semi-volatile organic leachables. Identities of compounds detected by GC/MS are often secured by mass spectral matching (MSM), where the mass spectrum is compared to reference spectra from a spectral library. Compounds whose reference spectrum closely matches the analytical spectrum are candidate identities for the compound of interest. Even when rigorously applied, MSM can lead to incorrect candidate identities. Avoiding misidentifications is important as reporting misidentified compounds can severely impact toxicological risk assessment, potentially leading to false conclusions about patient safety. The retention index (RI) is an effective means of evaluating an identity secured by MSM. The agreement between an experimental RI and a reference RI likely corroborates or refutes an MSM identity, although in certain cases the RI comparison may be inconclusive. The use of RI matching to corroborate MSM-based identities was investigated. Experimental and calculated RI values from the NIST23 library were compared to experimental RI values. Both classes of NIST23 RI values correlated well with the experimental RI obtained for 3140 compounds with confirmed identities, leading to the development of a strategy where reference RI-information from NIST23 can be used to support, accept, or reject candidate MSM structures. Using a confusion matrix, it is concluded that within the boundaries set for mass spectral matching (MSM>85; top 5 ranked candidates), an absolute difference in RI between the experimental value and the NIST reference value (|ΔRI|) of equal or lower than 20 showed a high identification precision and corroborates proposed identified. A |ΔRI| value higher than 50 showed a very low precision, which consequently rejects these identifications. |ΔRI| values between 20 and 50 are indiscriminate, meaning that while the identity proposed via MSM is accepted, it is considered to be tentative and uncorroborated.

PDA Journal of Pharmaceutical Science and Technology
Province of Antwerp (BE), Nelson Engineering (United States) (US)
Reduced inequalities
Openalex Percentile: Top 80%
Metabolomics and Mass Spectrometry Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.